1. Contract Summary & Primary Sources
| Contract Number (PIID) | SPE2DR-25-D-1901 (unhyphenated: SPE2DR25D1901) |
|---|---|
| Prime Contractor (Awardee) |
Amerisourcebergen Drug Corp
$COR
FY2024-FY2026 Federal Defense Portfolio: $19.0B obligated across 1,361,754 contracts
|
| Obligated Amount | Order-Dependent / TBD |
| Cumulative Face Value / Ceiling | USAspending Base IDV Ceiling: $999,999,999 |
| USAspending / FPDS Obligation History | Base Record Obligated: $0 (signed 2025-03-07, latest FPDS action 2025-03-07) · 15 Issued Delivery/Task Order(s) totaling $17,138,430 |
| Awarding Branch / Agency | Defense Logistics Agency |
| Contracting Command & DoDAAC | SPE2DR: DLA TROOP SUPPORT |
| Competition & Contract Structure | COMPETITION NOT STATED · Indefinite Delivery Contract (IDIQ) / Firm-Fixed-Price (FFP) |
| Product / Service & Industry Codes | PSC 6505 (Drugs And Biologicals) · NAICS 424210 (Drugs And Druggists' Sundries Merchant Wholesalers) |
| Work Locations & Funding | Determined at the contract or task-order level |
| Estimated Completion Date | See order schedule |
| Verified Primary Sources |
2. Verbatim Announcement & Scope Breakdown
USAspending / FPDS Transaction Description (Contract SPE2DR25D1901)
4600082993 pharmaceutical pv div - fsb
3. Subcontractor, Supply Chain & Capture Intelligence
For Tier-2 / Tier-3 Subcontractors & Suppliers
Subcontracting & Material Supply Window
- Prime Awardee: Amerisourcebergen Drug Corp
- Delivery Runway: Active through multi-year ordering period
- Requirement Scope: 4600082993 pharmaceutical pv div - fsb
- Federal Supply Class: PSC 6505 (Drugs And Biologicals)
- BD Action: Reference Prime Contract SPE2DR-25-D-1901 when contacting Amerisourcebergen Drug Corp Supply Chain / Small Business Liaison Officer.
For Competing Primes & Capture Managers
Buying Command & Recompete Posture
- Buying Command: SPE2DR (DLA TROOP SUPPORT)
- Acquisition Method: COMPETITION NOT STATED
- FOIA Jurisdiction: Defense Logistics Agency FOIA (Official Portal)
- Capture Action: Request Section B CLIN ceiling structure and Section C Statement of Work below to benchmark deliverable requirements.
Issued Task & Delivery Orders under SPE2DR-25-D-1901 (15 shown, $17.1M obligated)
| Order PIID | Obligated | Awardee | Start / Latest Action | End Date | Order Scope |
|---|---|---|---|---|---|
| SPE2DR26FTK1X | $9.0M | Amerisourcebergen Drug Corp | 2026-03-11 / 2026-03-11 | 2026-03-12 | 4571359638 smallpox vaccine |
| SPE2DR26FTJ2Z | $7.7M | Amerisourcebergen Drug Corp | 2026-01-16 / 2026-01-16 | 2026-01-20 | 4570650165 smallpox vaccine |
| SPE2DR26FTJ2X | $264K | Amerisourcebergen Drug Corp | 2026-01-13 / 2026-01-13 | 2026-01-14 | 4570486826 smallpox vaccine |
| SPE2DR26FTL1A | $14K | Amerisourcebergen Drug Corp | 2026-03-27 / 2026-03-27 | 2026-03-30 | 4571298190 albuterol sulfate |
| SPE2DR26FTL3Y | $13K | Amerisourcebergen Drug Corp | 2026-04-28 / 2026-04-28 | 2026-04-29 | 4571645662 albendazole tablets |
| SPE2DR26FTJ4P | $13K | Amerisourcebergen Drug Corp | 2026-03-06 / 2026-03-06 | 2026-03-09 | 4571098224 albendazole tablets |
| SPE2DR26FTJ4G | $13K | Amerisourcebergen Drug Corp | 2026-03-06 / 2026-03-06 | 2026-03-09 | 4571098256 albendazole tablets |
| SPE2DR26FTL1D | $11K | Amerisourcebergen Drug Corp | 2026-04-20 / 2026-04-20 | 2026-05-11 | 4571689825 dantrolene sodium pdr |
| SPE2DR26FTL8L | $11K | Amerisourcebergen Drug Corp | 2026-06-05 / 2026-06-05 | 2026-06-29 | 4572210401 dantrolene sodium pdr |
| SPE2DR26FTK2X | $10K | Amerisourcebergen Drug Corp | 2026-03-25 / 2026-03-25 | 2026-04-15 | 4571264102 globulin tetanus immu |
| SPE2DR26FTL0E | $10K | Amerisourcebergen Drug Corp | 2026-03-26 / 2026-03-26 | 2026-04-16 | 4571293644 globulin tetanus immu |
| SPE2DR26FTJ2H | $9K | Amerisourcebergen Drug Corp | 2025-12-30 / 2025-12-30 | 2025-12-31 | 4570376282 levonorgestrel/ethiny |
| SPE2DR26FTK3U | $9K | Amerisourcebergen Drug Corp | 2026-03-25 / 2026-03-25 | 2026-03-26 | 4571272983 sodium chloride injec |
| SPE2DR26FTH4V | $8K | Amerisourcebergen Drug Corp | 2025-12-11 / 2025-12-11 | 2025-12-12 | 4570250590 epinephrine injection |
| SPE2DR26FTK7L | $8K | Amerisourcebergen Drug Corp | 2026-03-26 / 2026-03-26 | 2026-03-27 | 4571290269 sodium chloride injec |
Tier-2 Subcontract Reporting Status (FAR 52.204-10): Prime contractors report first-tier subcontracts of $30,000 or more to the Federal Subaward Reporting System (FSRS) by the end of the month following subcontract award. Under DFARS 252.219-7003, prime awards exceeding $750,000 ($1.5M for construction) carry mandatory small-business subcontracting plans. Component and subsystem suppliers should contact Amerisourcebergen Drug Corp Supply Chain / Small Business Liaison referencing contract SPE2DR-25-D-1901.
4. Underlying Contract Files (Section B Pricing & Section C Statement of Work)
Document Status: Not yet on file. The government publishes the award notice and obligation record above, but does not post the underlying Section C Statement of Work (SOW), Section B line-item pricing schedule (CLINs), or Sole-Source Justification & Approval (J&A) online.
Free DIY 5 U.S.C. 552 Generator ($0 Cost)
Pre-Filled FOIA Request Letter for SPE2DR-25-D-1901
Routed to Defense Logistics Agency FOIA · Official Agency FOIA Portal ↗
Optional Anonymous Filing via AwardTape Research: Prefer to keep your company name off the agency's public FOIA log? Enter your work email and AwardTape will track or file this request under AwardTape Research and email you when the agency responds.